Zhoutian Yang

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0009-0007-0261-8479

发表论文 6 篇 · 总被引 130 次 · h-index 5

代表论文

• Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Small Hepatocellular Carcinoma: A Randomized, Open-Label, Controlled Trial (2024 · Journal of Clinical Oncology · 被引 60)
• NAT10-mediated mRNA N4-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemia (2024 · Nature Cell Biology · 被引 46)
• Comparison of resection, ablation, and stereotactic body radiation therapy in treating solitary hepatocellular carcinoma ≤5 cm: a retrospective, multicenter, cohort study (2024 · International Journal of Surgery · 被引 13)
• Stereotactic body radiotherapy is an alternative to radiofrequency ablation for single HCC ≤5.0 cm (2024 · JHEP Reports · 被引 6)
• Efficacy and safety of atezolizumab–bevacizumab vs pembrolizumab-lenvatinib in unresectable hepatocellular carcinoma: a retrospective, cohort study (2024 · Frontiers in Immunology · 被引 5)
• Hepatic arterial interventional therapies alone or in combination with molecular targeted therapies and PD-(L)1 inhibitors in locally aggressive, early recurrent hepatocellular carcinoma: a retrospective study (2025 · Frontiers in Immunology)